Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial

CONTEXT Tamoxifen is approved for the reduction of breast cancer risk, and raloxifene has demonstrated a reduced risk of breast cancer in trials of older women with osteoporosis. OBJECTIVE To compare the relative effects and safety of raloxifene and tamoxifen on the risk of developing invasive breas...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA : the journal of the American Medical Association 2006-06, Vol.295 (23), p.2727-2741
Hauptverfasser:	Vogel, Victor G, Costantino, Joseph P, Wickerham, D. Lawrence, Cronin, Walter M, Cecchini, Reena S, Atkins, James N, Bevers, Therese B, Fehrenbacher, Louis, Pajon, Eduardo R, Wade, James L, Robidoux, André, Margolese, Richard G, James, Joan, Lippman, Scott M, Runowicz, Carolyn D, Ganz, Patricia A, Reis, Steven E, McCaskill-Stevens, Worta, Ford, Leslie G, Jordan, V. Craig, Wolmark, Norman, National Surgical Adjuvant Breast and Bowel Project (NSABP), for the
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Biological and medical sciences Breast cancer Breast Neoplasms - epidemiology Breast Neoplasms - prevention & control Cataract - epidemiology Cause of Death Clinical trials Double-Blind Method Drug therapy Female Fractures, Bone - epidemiology General aspects Gynecology. Andrology. Obstetrics Humans Incidence Mammary gland diseases Medical sciences Medical treatment Middle Aged Myocardial Ischemia - epidemiology Raloxifene Hydrochloride - therapeutic use Risk Risk factors Selective Estrogen Receptor Modulators - therapeutic use Tamoxifen - therapeutic use Thrombosis - epidemiology Tumors Uterine Neoplasms - epidemiology Womens health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!